<DOC>
	<DOCNO>NCT00211315</DOCNO>
	<brief_summary>Congenital Telangiectasia Coat 's disease uncommon disorder involve growth blood vessel macula . These blood vessel msy extend beneth retina produce area sub-retinal neovascularization ( growth abnormal blood vessel retina `` leak '' fluid , cause reduction vision ) . Limited form treatment available manage neovascularization consequence . Anecortave Acetate injection consider attempt control growth abnormal blood vessel .</brief_summary>
	<brief_title>Treatment Congenital Telangiectasia ( Coat 's Disease ) With Open-label Anecortave Acetate ( 15mg . )</brief_title>
	<detailed_description>After evaluation , patient receive injection anecortave acetate ( 15mg ) juxtascleral special cannula study eye . patient contact via phone day follow injection . If problem arise patient come back see study doctor . patient stable , 3 month follow-up visit st-up.if patient show improvement , patient may offer either thermal laser PDT . If patient stable , month 6 visit , patient receive another injection anecortave acetate . The succeding follow-up schedule follow total 24 month .</detailed_description>
	<mesh_term>Retinal Telangiectasis</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<criteria>1 . Clinical diagnosis congenital Telangiectasia ( Coat 's Disease ) . 2 . Patients must 18 year age older receive treatment . 3 . Visual acuity 20/30 20/320 Study Eye ETDRS visual acuity chart . 4 . Visual acuity 20/800 good Fellow Eye ETDRS visual acuity chart . 1 . Patient significantly compromise visual acuity study eye due concomitant ocular condition . 2 . Patients undergone intraocular surgery within last 2 month . 3 . Patient participate investigational drug study . 4 . Use investigational drug treatment relate unrelated condition within 30 day prior receipt study medication . 5 . Inability obtain photographs document CNV ( include difficulty venous access ) . 6 . Patient significant liver disease uremia . 7 . Patient known adverse reaction fluorescein indocyanine green iodine . 8 . Patient history medical condition would preclude schedule visit completion study . 9 . Patient insertion scleral buckle study eye 10 . Patient receive radiation treatment . 11 . Patient anticoagulant therapy exception aspirin . 12 . Patient pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>